Compare BLDR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | BAX |
|---|---|---|
| Founded | 1998 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.2B |
| IPO Year | 2005 | 1994 |
| Metric | BLDR | BAX |
|---|---|---|
| Price | $82.47 | $16.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 9 |
| Target Price | ★ $132.29 | $22.13 |
| AVG Volume (30 Days) | 2.3M | ★ 8.7M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $15,190,638,000.00 | $11,244,000,000.00 |
| Revenue This Year | $1.00 | $1.90 |
| Revenue Next Year | $4.52 | $2.22 |
| P/E Ratio | $20.28 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $78.55 | $15.73 |
| 52 Week High | $151.03 | $33.83 |
| Indicator | BLDR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 43.15 |
| Support Level | $80.00 | N/A |
| Resistance Level | $130.47 | $18.89 |
| Average True Range (ATR) | 3.54 | 0.76 |
| MACD | 0.27 | 0.01 |
| Stochastic Oscillator | 30.35 | 41.24 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.